Sector

Key takeaways from the Association for Accessible Medicines’ Access! 2024 meeting

The Indiana-based CDMO is redefining injectable drug manufacturing with community collaboration and technology

The San Francisco-based IDMO says its differentiated technology will allow pharma companies to unlock massive productivity gains in cell therapy — and save the lives of millions...

With a dual mission to serve both patients and the planet, the Switzerland-based CDMO takes on today’s most complex sterile medicines

Four young companies built with intention tackle the future of medicine

Though excipients are a necessary drug component that can often be taken for granted, the ever-changing pharma landscape is always pushing us to shift our perspectives.

Modern-day medications might finally mean obesity can be viewed as treatable

Companies prioritizing optimized synthetic routes, stable API forms, and verified analytical tools set the stage for phase I clinical manufacturing success

Novel techniques for mRNA delivery, capping and more will be key to producing more effective vaccines

Biopharma facilities must address the specific needs and concerns of this dynamic sector